ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Commence™ and The Language Group Launch Fetch, a Patent-Pending Translation Solution, to Improve Patient Outcomes

Fetch integrates real-time, AI-powered, human-reviewed translation into Electronic Health Record (EHR) systems, saving millions in preventable costs and improving care for non-English-speaking patients.

Today, Commence together with The Language Group (TLG) announced the launch of Fetch, a first-of-its-kind, patent-pending solution that delivers real-time, AI-powered, human-reviewed translations of patient discharge instructions directly within electronic health record (EHR) systems.

Designed for rapid scaling across commercial health environments, this solution addresses a critical gap in healthcare communication: enabling patients with limited English proficiency (LEP) to leave the hospital with clear, accurate, and understandable instructions in their preferred language. By automating translation and embedding it into standard discharge workflows, the solution improves patient understanding, reduces costly readmissions, and supports compliance with federal requirements.

“Language access shouldn’t be a paperwork burden—it should be a strategic advantage,” said Alex Payne, Vice President of Sales at Commence. “Our solution turns complex translation workflows into streamlined, measurable, and scalable operations that help hospitals deliver care patients understand.”

Solving a Costly and Widespread Challenge

One large integrated health system serving 150-200 limited-English proficient (LEP) patients per day estimated readmissions among patients discharged without translated instructions at 14% with an average cost of $15,200 per readmission. A system of this size could expect to save more than $4.6 million annually with Fetch.

Commence's Translation Solution, Fetch, Delivers

  • Patent-pending, AI-powered translation with human review
  • Seamless integration with EHR platforms, including Epic
  • Epic Showroom approval and listing
  • Delivery of discharge instructions in minutes
  • Unified dashboards for utilization, compliance, and cost tracking

The solution is built to meet the highest standards for patient safety and regulatory compliance, including -

  • Section 1557 of the Affordable Care Act
  • Title VI and CLAS standards
  • Joint Commission requirements
  • HIPAA and SOC 2 Type II compliance
  • ISO 18587 certified

For decades, providers have relied on fragmented, manual translation workflows to meet language needs—often hours or days after the point of care. Commence changes that. By combining AI-powered translation with clinical review, the platform enables hospitals to deliver accurate, timely, and understandable care instructions before a patient even leaves the room.

The solution fits seamlessly into existing discharge workflows, eliminating delays, reducing risk, and improving outcomes for diverse patient populations.

About Commence

Commence creates data-centered healthcare solutions that deliver measurable outcomes across federal, state, and commercial markets. By combining clinical expertise, innovative technology, and real-world data, Commence helps agencies and providers streamline operations, improve care quality, and reduce risk across complex health programs.

Headquartered in Virginia Beach, Commence supports over 200 clients nationwide and serves 60% of the Medicare population. Whether accelerating reviews, reducing costs, or transforming workflows, Commence empowers health organizations to perform beyond the scope with clarity and compassion.

Learn more at commence.ai.

About The Language Group

The Language Group (TLG) is a trusted provider of professional language solutions, specializing in translation, localization, and interpretation services. With ISO 17100 and ISO 18587 certifications, TLG delivers high-quality, technology-driven language services to industries including healthcare, legal, and corporate enterprises.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.